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Highlights
• PEGylated liposomes strictly made from palmitic acid and cholesterol are created 
Introduction
Liposomes are biocompatible, biodegradable, biologically inert, weakly immunogenic, and they display several advantages for drug vectorization.
1-2 They can provide a slow release that expands the period during which the drug level remains in the therapeutic window, they can target, passively or actively, specific sites, and they can reduce the acute toxicity of drugs. One of the limitations of liposomes used as drug carriers for intravenous administration, however, is their rapid capture and removal from the blood circulation by the mononuclear phagocyte system (MPS), leading to their accumulation in the liver and the spleen. Because it leads to a tighter chain packing, the incorporation of cholesterol in liposomes reduces the transfer of lipids to high-density lipoproteins and prevents blood-protein binding, extending the liposome circulation lifetime in the blood stream. [3] [4] [5] A major breakthrough for improving circulation time and reducing MPS uptake was the introduction of gangliosides and sialic acid derivatives, such as monosialoganglioside (GM1) [6] [7] at the water/liposome interface. A similar effect was observed with interfacial polyethylene glycol (PEG). [8] [9] [10] This protective effect has been associated with the steric stabilization of liposomes that inhibits the uptake by MPS and prolongs the liposome circulation lifetime. 6, [8] [9] 11 The origin of this protection is still not fully understood but it has been proposed that the reduced binding of plasma proteins, including potential opsonizing factors, the limitation of direct interactions with cells of the reticuloendothelial system, and the inhibition of liposome-liposome aggregation could contribute to the reduced clearance of PEGylated liposomes [12] [13] [14] [15] [16] [17] [18] .
PEG is an appealing macromolecule for obtaining sterically-stabilized liposomes as it displays biocompatibility, low toxicity, low immunogenicity and antigenicity, and good excretion kinetics. 2 Furthermore, its molecular weight can be easily modulated and it is relatively cheap to produce. It has been shown that PEG with a molecular weight between 1000, and 5000, anchored on bilayers with a phosphatidylethanolamine (PE) moiety displays a good miscibility with phospholipids; up to ∼10 mol% PEG could be grafted without observing phase separation or micelle formation. 13, 19 It was shown that improved circulation times of liposomes in the blood stream were obtained for liposomes with 2-10 mol% of interfacial PEG with a molecular weight between 350 and 2000 (anchored with distearoylphosphatidylethanolamine (DSPE) in these studies). 12, 16 The protection of liposomes against phagocytosis was also improved with introducing PEG with a molecular weight of 2000 at its interface. 9 An increase of the PEG molecular weight to 5000 had no effect on half-life time of liposomes in the blood stream or, in some reports, slightly decreased it. 9 The anchoring of PEG at the liposome interface is achieved by covalently attaching PEG to a phospholipid or a sterol. Because of the reactivity of the amine group, PEG-phosphatidylethanolamine (PEG-PE) is commonly used. 2 PEG-coupled with ceramide has also been synthesized as a neutral alternative. 20 Ishiwata and coll. 21 used a sterol anchored PEG for modifying liposome surface. PEGylated cholesteryl ether led to an increased liposome circulation time in the blood stream similar to that previously obtained with PEG-DSPE. [21] [22] [23] PEG cholesteryl ester was also synthesized and incorporated in phospholipid liposomes and niosomes to achieve long circulation lifetime. [23] [24] As a hydrophobic anchor for PEG, cholesterol is an alternative that presents distinct advantages. First, the chain ordering effects of cholesterol lead to less permeable bilayers. Second, it is neutral and this property provides a reduced binding of plasma proteins to liposomes. Third, cholesterol is chemically stable, a useful feature regarding storage.
It has been shown that it is possible to form non-phospholipid liposomes with single-chain amphiphiles and sterols -for a review, see [25] [26] . The binary mixtures that could successfully form liposomes include negatively charged mixtures of unprotonated palmitic acid (PA) or its analogues with cholesterol (Chol) or some other sterols. [27] [28] [29] A distinct feature of these non-phospholipid liposomes is their high sterol content, which is between 50 and 70 mol%. This peculiar composition leads to a permeability that is drastically limited compared to traditional phospholipid liposomes. For example, it was found that about 70% of entrapped calcein, a negatively charged fluorophore, was still encapsulated after 1.5 years. 28 In addition, these liposomes are pH sensitive when they include a fatty acid or an alkylated primary amine as the single-chain amphiphile. The pH-triggered release could be fine-tuned by selecting a fatty acid with an appropriate pKa.
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These non-phospholipid sterol-rich liposomes display an interesting potential as drug nanovectors. Their constituents are significantly more stable from a chemical point of view in aqueous suspension than phospholipids. Because of their very limited permeability, they could present a valuable alternative for drug encapsulation especially in the cases of challenging drugs that leak rapidly from conventional phospholipid liposomes such as 5-FU. 30 In these cases, it has been shown that it was difficult to retain the drug inside phospholipid-based liposomes, preventing the development of liposomal formulations for intravenous therapy displaying extended blood circulation lifetime and improved therapeutic activities. The restricted leakage observed for liposomes prepared with single-chain amphiphiles and sterols could therefore be advantageous in that context. In order to obtain a sustained drug release in parenteral delivery, nanovectors should also display a long circulation lifetime in the blood stream. Preliminary pharmaco-kinetics studies showed that, despite the very tight lipid chain packing that could limit protein adsorption, the sterol-rich PA/Chol liposomes were cleared very rapidly (less than 30 minutes) from the blood stream in rats (unpublished results). In the present study, we examined the possibility of introducing PEGylated cholesterol (PEG-Chol) in non-phospholipid liposomes made of PA/Chol mixtures in order to combine the incomparably low permeability of those with improved blood circulation lifetime. We determined the impact of the incorporation of PEG-Chol on the stability of these unusual bilayers using deuterium and pulsed-field-gradient 1 H NMR, as well as cryo-transmission electron microscopy. We established the amount of PEG-Chol that could be included in the non-phospholipid bilayers without significant perturbation. We examined also the possibility to extrude the ternary mixtures to form large unilamellar vesicles (LUVs) and characterized the stability, the permeability and the pH sensitivity of the resulting liposomes. These findings provided us with a more detailed understanding of the influence of the hydration of the liposome interface on the stability of these self-assemblies. The present study also displays the feasibility of actively loading a drug in these non-phospholipid vesicles. Active loading is an advantageous way to obtain high drug loading efficiency and high drug to lipid ratios, two parameters presenting considerable benefit for therapeutic purposes and the pharmaceutical industries. Because these liposomes with high sterol content are very impermeable, active loading may present a specific challenge. We have therefore investigated whether LUVs prepared from PA/Chol/PEG-Chol mixtures could be actively loaded with doxorubicin (DOX), a broad-spectrum anticancer drug. Liposomal DOX has been shown to have improved therapeutic index and decreased toxicity. [31] [32] It is somehow a benchmark regarding drug active loading. DOX is an amphipathic weak base that can be actively loaded into the aqueous compartment of phospholipid liposomes through ammonium sulphate gradient with a high drug loading efficiency. The ammonium sulphate gradient approach does not require the preparation of liposomes in acidic pH, nor to alkalinize the extraliposomal aqueous phase, by contrast with other chemical approaches used for active loading. 33 Finally, we conducted pharmaco-kinetic experiments in rats in order to determine the effect of interfacial PEG on the blood circulation lifetime and the biodistribution of PA/Chol/PEG-Chol liposomes. The pharmaco-kinetics was examined using DiD, a fluorescent lipophilic probe that labels the LUV walls and has, in general, limited transfer from labeled to unlabeled membranes. The diffusion coefficients were measured using the stimulated echo pulse sequence 35 . Trapezoidal gradient pulses (δ) of 1.50 ms and interpulse delays (Δ) of 100 ms were applied. Typically, 32 scans were co-added for a given gradient strength and 32 gradient magnitudes were used for each attenuation curve. The sample temperature was controlled using the gradient coil cooling unit, and was calibrated using ethylene glycol. The diffusion coefficients were obtained by fitting the variation of the echo intensity as a function of the gradient strength (G) using the following equation:
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Materials and Methods
Materials
where S and S 0 are the integrated echo intensities with and without a field gradient and γ the gyromagnetic ratio of protons. All the curves could be well fitted with this single-diffusion-coefficient model.
LUVs Characterization. The hydrodynamic diameters of the LUVs were measured at 25
ºC by dynamic light scattering (DLS) using a Malvern nanosizer. The curve fittings of correlation functions were performed using an exponential fit (CONTIN approach) for size (hydrodynamic diameter) determination. The scattering light intensity was adjusted by diluting the dispersions with the MES/TRIS buffer.
The conditions for the cryogenic transmission electron microscopy (Cryo-TEM) technique are detailed elsewhere. 36 Briefly, an aliquot of a LUV sample (~ 1 µL) was deposited on a copper grid covered with a carbon-reinforced holey polymer film, dabbed with a filter paper to form a thin film (10-500 nm) and incubated in a custom-built climate chamber at 25 °C and >99% relative humidity. The grid was then plunged into liquid ethane held at a temperature just above its freezing point (-183 °C). The vitrified sample was kept below -165 °C and protected from ambient conditions during the transfer from the preparation chamber to the microscope as well as during the data acquisition. The micrographs were obtained using a Zeiss EM 902A Transmission Electron Microscope (Carl Zeiss NTS, Oberkochen, Germany), in the zero loss bright-field mode, with an accelerating voltage of 80 kV. The digital images were recorded under a low dose conditions with a BioVision Pro-SM slow scan CCD camera (Proscan GmbH, Scheuring, Germany). Their contrast was enhanced using an underfocus of 1-2 µm.
Permeability Measurements. The permeability of the LUVs was measured using a standard procedure based on the self-quenching property of calcein at high concentration. 28, 37 Briefly, LUVs loaded with the fluorophore were prepared from PA/Chol/PEG-Chol mixtures hydrated with a MES/TRIS buffer, pH 8.4, containing 80 mM of calcein; the resulting MLV suspension was extruded, using filters with 100 nm-pore diameter. The calcein-containing LUVs were separated from free calcein by gel permeation chromatography, using Sephadex G-50
Medium gel (column diameter: 1.5 cm, length: 25 cm), equilibrated with an iso-osmotic MES/TRIS buffer (MES 50 mM, TRIS 50 mM, NaCl 130 mM, EDTA 5 mM, pH 8.4). The collected vesicle fraction was diluted 100 times with buffers having different pH to obtain a final fatty acid concentration of about 20 µM. This dilution step was set as time = 0. These stock LUV suspensions were then incubated at room temperature.
To study the passive leakage (external and internal pH of 8.4), the calcein fluorescence intensity was measured from an aliquot of the stock LUV suspension freshly isolated by gel permeation chromatography, prior (I i ) and after (I i+T ) the addition of Triton X-100 (10 µL of a 10 (v/v)% solution prepared in the MES/TRIS buffer). The low fluorescence intensity measured prior to the detergent addition was associated to calcein that was initially completely encapsulated whereas the fluorescence intensity measured after addition of Triton X-100 corresponded to the complete release of entrapped calcein.
After a given incubation time, the calcein fluorescence intensity was measured on another aliquot of the same stock LUV suspension before (I f ) and after (I f+T ) the addition of Triton X-100.
The percentage of encapsulated calcein at that time in the LUVs was calculated according to:
% of encapsulated calcein
The % of release corresponded to (100 -% of encapsulated calcein).
The pH-triggered leakage of calcein was also examined. The percentage of released calcein was calculated using Equation 2: I i and I i+T were measured at pH 8.4, the initial pH, before and after the addition of Triton X-100 respectively, whereas I f and I f+T were obtained on an aliquot at a modified pH, before and after the addition of Triton X-100 respectively. The pH effect was examined for an increase as well as a decrease in pH. Calcein fluorescence intensity was relatively constant over the investigated pH range. 37 The fluorescence intensities were recorded using a Photon Technology International spectrofluorometer. The excitation and emission wavelengths were 490 and 513 nm respectively and the band path widths were set to 1.0 and 1.6 nm for the excitation and emission monochromators, respectively. DOX Active Loading Experiments. Active loading of doxorubicin was carried out using an ammonium sulfate gradient. 33 PA/Chol/PEG-Chol solid mixtures were hydrated with an ammonium sulfate solution (120 mM). The PA/Chol/PEG-Chol LUVs (extruded using filters with 100-nm diameter pores) were prepared as described above. The ammonium sulfate gradient was created by gel permeation chromatography, using Sephadex G-50 Medium gel (column diameter: 1.5 cm, length: 25 cm), equilibrated with an iso-osmotic NaCl solution (150 mM). An aliquot of a DOX solution (5 mM, prepared in water containing 150 mM NaCl) was added to the collected vesicles (~ 3 mg of lipids/mL) in order to have a DOX/lipid molar ratio of 1/15. The LUVs suspensions were incubated at ~70 o C for 24 hours. In order to determine the drug loading efficiency, the LUV suspensions incubated with DOX were diluted 100-folds with the NaCl solution. Converted Dowex ® 50WX4 resin was added to an aliquot to remove the free DOX by complexation. The sample was centrifuged at 4000 rpm for 3 min and DOX absorbance at 480 nm was measured. The absorbance was also measured for an aliquot without resin to obtain the total amount of DOX. The release of liposome-entrapped DOX was also characterized by UV-vis spectroscopy using the resin treatment to eliminate the released drug. HPLC-MS analysis was carried out on LUV aliquots treated with the resin in order to quantify the drug to lipid ratio.
Pharmacokinetics and biodistribution. Sprague-Dawley rats (300-350 g) (Charles
River, L'Arbresle, France) were housed and maintained at the University animal facility PA/Chol, PA/Chol/PEG-Chol or DSPC/Chol/PEG-DSPE LUVs in phosphate buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.76 mM KH 2 PO 4 , pH 7.4), were prepared as described above; the final lipid concentration was 7 mg of lipids/mL. DiD, used to label the LUV walls, was added to the organic lipid solution, before the freeze-drying step, to obtain a final DiD/lipid ratio of 2 (w/w)%. The LUV size and zeta potential were not affected by the presence of DiD, confirming that the fluorophore, at that concentration, did not affect the assembly. 
21, 43
The measured diffusion coefficient in these conditions was 2.0 × 10 -11 m 2 /s, a value corresponding to that reported for PEG2000-PE micelles. 42 
PA/Chol/PEG--Chol LUV permeability
The PA/Chol/PEG-Chol LUVs loaded with calcein were prepared by extrusion at pH 8. The permeability of the PA/Chol/PEG-Chol LUVs was also assessed as a function of pH ( Figure   6 ). As shown previously, 29 PA/Chol LUVs (30/70 molar ratio) are pH-sensitive: they were stable between pH 7 and 9.5 whereas a significant calcein release was observed for pH 6.0 or below.
Contrasting with this behavior, no significant calcein release was observed from the LUVs containing PEGylated cholesterol when the external pH was modified between 5.5 and 9.5. These results indicate that the presence of PEG-Chol in the LUVs impedes their pH sensitivity. 
DOX Active Loading and Release
The effectiveness of active loading using a transmembrane ammonium gradient was assessed for liposomes made of PA/Chol/PEG-Chol (30/60/10 molar ratio). The encapsulation efficiency of DOX was estimated to 84%, and the resulting drug to lipid ratio was 0.06 (molar ratio). These parameters are comparable to those previously obtained with phospholipid-based liposomes. [48] [49] [50] It should be pointed out that the reported trapping efficiency was very good since the drug to lipid ratio is expressed in molar terms and the investigated liposomes were formed from a single-chain amphiphile, in contrast to phospholipids, which bear two hydrophobic chains.
The stability and the passive release of DOX-loaded liposomes were also examined. The results are summarized in Figure 7 . It is shown that the non-phospholipid liposomes displayed a very limited permeability to DOX; the drug slowly leaked out from the LUVs and only ~20% of encapsulated DOX was released after a three-month period. The stability of DOX-loaded PA/Chol/PEG-Chol LUVs was significantly improved compared to active-loaded phosphophatidylcholine liposome containing 38 mol% of cholesterol and 5 mol% of PEG-lipid (PEG-DSPE or PEG-Chol). For those formulations, more than 30% of the encapsulated DOX was released within three days, in similar conditions. of the injected dose remained in the blood after 24 h, a result consistent with previous studies 51 .
The biodistribution after 24 h was determined for naked and PEGylated PA/Chol LUVs ( Figure 9) (the DSPC/Chol/PEG-PE LUVs remaining in the blood stream after 24 h would have interfered with the measurements, increasing the apparent distribution in the highly vascularized organs).
As expected, most of DiD was found in the liver for both formulations, indicative of the MPS uptake. 51 A significant quantity was also found in the spleen for PA/Chol LUVs. It appears that the presence of PEG at the interface has affected the biodistribution as, in addition to liver, a significant amount of DiD was also found in the lungs and the heart whereas less dye was found in the spleen, a phenomenon previously observed upon PEGylation of liposomes. 
Discussion
The present study reveals that it is possible to introduce PEGylated cholesterol into liposomes prepared from palmitic acid and cholesterol. At least 10 mol% of PEG-Chol can be included in the ternary system before non-liposomal structures start to appear. It has been shown that PA/Chol system forms stable fluid bilayers only at high pH (≥ 7.5)
while lower pH favors the formation of solid phase cholesterol and palmitic acid. 41 The protonation state of the carboxylic group dictates the bilayer stability through its modulation of the lipid mixing properties and the bilayer interface hydration. At lower pH, PA head group is protonated, favoring phase separation from cholesterol and reducing the hydration of the bilayer interface; as a consequence, the destabilization of the fluid lamellar phase is observed. 28, 45 In shifted the pH-trigged release curve towards more acidic regions and reduced the extent of the leakage that could be induced. 56 The presence of only 1 mol% PEG-DSPE in the formulation led to a decrease of release from >90% without PEG to ~20%, when the pH was set to 5. Similarly the pH-sensitivity of cholesteryl hemisuccinate/DOPE liposomes was attenuated in the presence of PEG-PE: 58 the nearly complete release of the liposome content could be trigged at pH 5, while the inclusion of 2 mol% PEG-PE reduced the pH-induced leakage to ~20%. Therefore, the presence of interfacial PEG changes the chemistry of the bilayer/aqueous milieu interface and attenuates the pH-response of functional groups such as the carboxylic group, leading to the reduction or even the loss of pH-responsiveness of PEGylated liposomes.
We also determined the performance of PA/Chol/PEG-Chol liposomes for active loading of DOX. It is shown that DOX could be successfully loaded in the aqueous compartment of these LUVs with a conventional approach based on an ammonium sulfate gradient. A high drug loading efficiency (84%) and a high drug to lipid ratio (0.06) were obtained, despite the much reduced bilayer permeability of these liposomes and the presence of interfacial PEG. The reported values are comparable to those reported for phospholipid liposomes. 
